Skip to main content
SpringerLink
Log in

Preoperative Cardiovascular Evaluation and Management

  • Chapter
  • First Online:
Kidney Transplantation

Abstract

Cardiovascular disease is a leading cause of morbidity and mortality among patients with end-stage renal disease (ESRD) including transplant candidates and recipients. Although transplantation improves cardiovascular risk in the long term compared with dialysis, cardiovascular diseases in aggregate comprise the most common cause of death in patients with functioning allografts at all times after kidney transplant. Achieving clinically and cost-effective management of cardiovascular disease in kidney transplant candidates is a challenging endeavor due to the large size of the target population, prevalent disease burden, and the often extended waiting periods between initial candidate evaluation and transplantation surgery. Further, there is a paucity of randomized clinical trials addressing the efficacy of cardiac screening, surveillance, coronary revascularization, and medical management among patients with ESRD, and extrapolation from trials performed in other populations or observational studies is often necessary to formulate practice recommendations. Recently, the American Heart Association and American College of Cardiology Foundation convened a working group including cardiologists, nephrologists, and intensivists to compose a Scientific Statement on “Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates.” The current chapter provides a practical summary of some of the key recommendations in this Scientific Statement relevant to kidney transplant candidates, focused as a practical guide for the clinician. Our synthesis includes a final algorithm emphasizing the importance of history and physical examination to assess for active cardiac conditions, use of resting echocardiography in dialysis patients to evaluate ventricular function and screen for valvular disease and pulmonary hypertension, and use of noninvasive stress testing in asymptomatic transplant candidates with three or more coronary disease risk factors to target screening on the subgroup with the highest pretest probability of prognostically significant coronary artery disease. Moving forward, we believe that pursuit of more evidence, ideally from randomized clinical trials, is an urgent priority to strengthen the evidence base for pretransplant cardiac evaluation and the management of cardiovascular disease before, during, and after transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant. 2004;4: 1662–8.

    PubMed  Google Scholar 

  2. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16:496–506.

    PubMed  Google Scholar 

  3. Lentine KL, Schnitzler MA, Abbott KC, et al. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis. 2005;46:720–33.

    PubMed  Google Scholar 

  4. Lentine KL, Rocca Rey LA, Kolli S, et al. Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol. 2008;3:1090–101.

    PubMed Central  PubMed  Google Scholar 

  5. Lentine KL, Xiao H, Brennan DC, et al. The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J. 2009;158:972–82.

    PubMed Central  PubMed  Google Scholar 

  6. Ramanathan V, Goral S, Tanriover B, et al. Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation. 2005;79:1453–8.

    PubMed  Google Scholar 

  7. Lentine KL, Schnitzler MA, Abbott KC, et al. Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol. 2006;1:288–96.

    PubMed  Google Scholar 

  8. Kasiske BL, Maclean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol. 2006;17:900–7.

    PubMed  Google Scholar 

  9. (OPTN) OPaTN. Organ Procurement and Transplant Network Database, Current US waiting list, kidney transplants. http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed 20 Jan 2014.

  10. Ramos EL, Kasiske BL, Alexander SR, et al. The evaluation of candidates for renal transplantation. The current practice of U.S. transplant centers. Transplantation. 1994;57:490–7.

    PubMed  CAS  Google Scholar 

  11. Danovitch GM, Hariharan S, Pirsch JD, et al. Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol. 2002;13:528–35.

    PubMed  Google Scholar 

  12. Zarifian A, O’Rourke M. Managing the kidney waiting list. Prog Transplant. 2006;16:242–6.

    PubMed  Google Scholar 

  13. Lentine KL, Schnitzler MA, Brennan DC, et al. Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol. 2008;3:1115–24.

    PubMed Central  PubMed  Google Scholar 

  14. Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2012;126:617–63.

    PubMed  Google Scholar 

  15. Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1 Suppl 2:3–95.

    PubMed  Google Scholar 

  16. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1–153.

    Google Scholar 

  17. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007;50:1707–32.

    PubMed  Google Scholar 

  18. Friedman A, ZLotnick D, Palac R, Costa S. A study in contradictions: rates of noninvasive stress testing in renal transplant candidates are dependent on which set of national guidelines are applied. Clin J Am Soc Nephrol. 2011;6:1185–91.

    Google Scholar 

  19. Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation. 2005;80:815–20.

    PubMed  Google Scholar 

  20. Lewis MS, Wilson RA, Walker K, et al. Factors in cardiac risk stratification of candidates for renal transplant. J Cardiovasc Risk. 1999;6:251–5.

    PubMed  CAS  Google Scholar 

  21. Patel AD, Abo-Auda WS, Davis JM, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol. 2003;92:146–51.

    PubMed  Google Scholar 

  22. Patel RK, Mark PB, Johnston N, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant. 2008;8:1673–83.

    PubMed  CAS  Google Scholar 

  23. Marwick TH, Steinmuller DR, Underwood DA, et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation. 1990;49:100–3.

    PubMed  CAS  Google Scholar 

  24. Boudreau RJ, Strony JT, duCret RP, et al. Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology. 1990;175:103–5.

    PubMed  CAS  Google Scholar 

  25. Vandenberg BF, Rossen JD, Grover-McKay M, Shammas NW, Burns TL, Rezai K. Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods. Transplantation. 1996;62:1230–5.

    PubMed  CAS  Google Scholar 

  26. Dahan M, Viron BM, Faraggi M, et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int. 1998;54: 255–62.

    PubMed  CAS  Google Scholar 

  27. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis. 1999;33:1080–90.

    PubMed  CAS  Google Scholar 

  28. Worthley MI, Unger SA, Mathew TH, Russ GR, Horowitz JD. Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure. Am J Cardiol. 2003;92:1318–20.

    PubMed  Google Scholar 

  29. De Lima JJ, Sabbaga E, Vieira ML, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension. 2003;42:263–8.

    PubMed  Google Scholar 

  30. Sharma R, Pellerin D, Gaze DC, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant. 2005;20:2207–14.

    PubMed  Google Scholar 

  31. Ferreira PA, de Lima VC, Campos Filho O, et al. Feasibility, safety and accuracy of dobutamine/atropine stress echocardiography for the detection of coronary artery disease in renal transplant candidates. Arq Bras Cardiol. 2007;88:45–51.

    PubMed  Google Scholar 

  32. Wang LW, Fahim MA, Hayen A, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev. 2011;(12):CD008691.

    Google Scholar 

  33. Ragosta M, Samady H, Isaacs RB, Gimple LW, Sarembock IJ, Powers ER. Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J. 2004;147(6):1017–23.

    PubMed  CAS  Google Scholar 

  34. Morrow CE, Schwartz JS, Sutherland DE, et al. Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg. 1983;146:331–5.

    PubMed  CAS  Google Scholar 

  35. Reis G, Marcovitz PA, Leichtman AB, et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol. 1995;75:707–10.

    PubMed  CAS  Google Scholar 

  36. Bates JR, Sawada SG, Segar DS, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol. 1996;77:175–9.

    PubMed  CAS  Google Scholar 

  37. Tita C, Karthikeyan V, Stroe A, Jacobsen G, Ananthasubramaniam K. Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation. J Am Soc Echocardiogr. 2008;21:321–6.

    PubMed  Google Scholar 

  38. Marwick TH, Lauer MS, Lobo A, Nally J, Braun W. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med. 1998;244:155–61.

    PubMed  CAS  Google Scholar 

  39. Rakhit DJ, Armstrong KA, Beller E, Isbel NM, Marwick TH. Risk stratification of patients with chronic kidney disease: results of screening strategies incorporating clinical risk scoring and dobutamine stress echocardiography. Am Heart J. 2006;152:363–70.

    PubMed  Google Scholar 

  40. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol. 2003;14:431–9.

    PubMed  Google Scholar 

  41. Bergeron S, Hillis GS, Haugen EN, Oh JK, Bailey KR, Pellikka PA. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J. 2007;153:385–91.

    PubMed  Google Scholar 

  42. Wong CF, Little MA, Vinjamuri S, Hammad A, Harper JM. Technetium myocardial perfusion scanning in prerenal transplant evaluation in the United Kingdom. Transplant Proc. 2008;40:1324–8.

    PubMed  CAS  Google Scholar 

  43. Bennett WM, Kloster F, Rosch J, Barry J, Porter GA. Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease. Am J Med. 1978;65:779–84.

    PubMed  CAS  Google Scholar 

  44. Weinrauch L, D’Elia JA, Healy RW, Gleason RE, Christleib AR, Leland Jr OS. Asymptomatic coronary artery disease: angiographic assessment of diabetics evaluated for renal transplantation. Circulation. 1978;58:1184–90.

    PubMed  CAS  Google Scholar 

  45. Braun WE, Phillips DF, Vidt DG, et al. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc. 1984;16:603–7.

    PubMed  CAS  Google Scholar 

  46. Lorber MI, Van Buren CT, Flechner SM, et al. Pretransplant coronary arteriography for diabetic renal transplant recipients. Transplant Proc. 1987;19:1539–41.

    PubMed  CAS  Google Scholar 

  47. Manske CL, Wilson RF, Wang Y, Thomas W. Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy. Arch Intern Med. 1992;152:2450–5.

    PubMed  CAS  Google Scholar 

  48. Ohtake T, Kobayashi S, Moriya H, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol. 2005;16:1141–8.

    PubMed  Google Scholar 

  49. Charytan D, Kuntz RE, Mauri L, DeFilippi C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007;49:409–16.

    PubMed  Google Scholar 

  50. Gowdak LH, de Paula FJ, Cesar LA, et al. Screening for significant coronary artery disease in high-risk renal transplant candidates. Coron Artery Dis. 2007;18:553–8.

    PubMed  Google Scholar 

  51. Gowdak LH, de Paula FJ, Cesar LA, et al. Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates. Nephrol Dial Transplant. 2007;22:1456–61.

    PubMed  Google Scholar 

  52. Hage FG, Smalheiser S, Zoghbi GJ, et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol. 2007;100:1020–5.

    PubMed  Google Scholar 

  53. Hickson LJ, Cosio FG, El-Zoghby ZM, et al. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant. 2008;8:2352–9.

    PubMed  CAS  Google Scholar 

  54. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet. 1992;340:998–1002.

    PubMed  CAS  Google Scholar 

  55. Kumar N, Baker CS, Chan K, et al. Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation. Clin J Am Soc Nephrol. 2011;6: 1912–9.

    PubMed Central  PubMed  Google Scholar 

  56. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795–804.

    PubMed  CAS  Google Scholar 

  57. Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.

    PubMed  CAS  Google Scholar 

  58. Sedlis SP, Jurkovitz CT, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol. 2009;104:1647–53.

    PubMed  Google Scholar 

  59. Abbud-Filho M, Adams PL, Alberu J, et al. A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation. 2007;83:S1–22.

    PubMed  Google Scholar 

  60. Gaston RS, Danovitch GM, Adams PL, et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant. 2003;3:775–85.

    PubMed  Google Scholar 

  61. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.

    PubMed  Google Scholar 

  62. Hakeem A, Bhatti S, Dillie KS, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation. 2008;118:2540–9.

    PubMed  Google Scholar 

  63. Rakhit DJ, Marwick TH, Armstrong KA, Johnson DW, Leano R, Isbel NM. Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart. 2006;92:1402–8.

    PubMed Central  PubMed  CAS  Google Scholar 

  64. Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol. 2005;16:808–16.

    PubMed  Google Scholar 

  65. Abe S, Yoshizawa M, Nakanishi N, et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J. 1996;131:1137–44.

    PubMed  CAS  Google Scholar 

  66. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005;45:43–9.

    PubMed  Google Scholar 

  67. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–92.

    PubMed  CAS  Google Scholar 

  68. Yamada S, Ishii H, Takahashi H, et al. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol. 2010;5:1793–8.

    PubMed Central  PubMed  Google Scholar 

  69. Siedlecki A, Foushee M, Curtis JJ, et al. The impact of left ventricular systolic dysfunction on survival after renal transplantation. Transplantation. 2007;84:1610–7.

    PubMed  Google Scholar 

  70. de Mattos AM, Siedlecki A, Gaston RS, et al. Systolic dysfunction portends increased mortality among those waiting for renal transplant. J Am Soc Nephrol. 2008;19:1191–6.

    PubMed Central  PubMed  Google Scholar 

  71. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49:1860–70.

    PubMed  Google Scholar 

  72. Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–6.

    PubMed Central  PubMed  CAS  Google Scholar 

  73. Blaha MJ, Budoff MJ, DeFilippis AP, et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet. 2011;378:684–92.

    PubMed Central  PubMed  CAS  Google Scholar 

  74. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39:695–701.

    PubMed  Google Scholar 

  75. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394–401.

    PubMed  CAS  Google Scholar 

  76. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–83.

    PubMed  CAS  Google Scholar 

  77. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–5.

    PubMed  Google Scholar 

  78. Matsuoka M, Iseki K, Tamashiro M, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004;8:54–8.

    PubMed  Google Scholar 

  79. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49:378–402.

    PubMed  Google Scholar 

  80. Haydar AA, Hujairi NM, Covic AA, Pereira D, Rubens M, Goldsmith DJ. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant. 2004;19:2307–12.

    PubMed  Google Scholar 

  81. Sharples EJ, Pereira D, Summers S, et al. Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis. 2004;43:313–9.

    PubMed  Google Scholar 

  82. Tong LL, Mehrotra R, Shavelle DM, Budoff M, Adler S. Poor correlation between coronary artery calcification and obstructive coronary artery disease in an end-stage renal disease patient. Hemodial Int. 2008;12:16–22.

    PubMed  Google Scholar 

  83. Shroff RC, McNair R, Figg N, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118:1748–57.

    PubMed  CAS  Google Scholar 

  84. Vanhoenacker PK, Heijenbrok-Kal MH, Van Heste R, et al. Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis. Radiology. 2007;244:419–28.

    PubMed  Google Scholar 

  85. Meijboom WB, Weustink AC, Pugliese F, et al. Comparison of diagnostic accuracy of 64-slice computed tomography coronary angiography in women versus men with angina pectoris. Am J Cardiol. 2007;100:1532–7.

    PubMed  Google Scholar 

  86. Hulten EA, Carbonaro S, Petrillo SP, Mitchell JD, Villines TC. Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;57:1237–47.

    PubMed  Google Scholar 

  87. Taylor AJ, Cerqueira M, Hodgson JM, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2011;56:1864–94.

    Google Scholar 

  88. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006;48:1–11.

    PubMed  CAS  Google Scholar 

  89. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation. 2005;112:3088–96.

    PubMed  CAS  Google Scholar 

  90. Hickson LT, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant. 2009;9:1354–61.

    PubMed  CAS  Google Scholar 

  91. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Troponin T is an independent predictor of mortality in renal transplant recipients. Nephrol Dial Transplant. 2008;23:1019–25.

    PubMed  CAS  Google Scholar 

  92. Bonaca M, Scirica B, Sabatine M, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol. 2010;55:2118–24.

    PubMed  CAS  Google Scholar 

  93. Lewis MS, Wilson RA, Walker KW, et al. Validation of an algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol. 2002;89:847–50.

    PubMed  Google Scholar 

  94. Le A, Wilson R, Douek K, et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis. 1994;24:65–71.

    PubMed  CAS  Google Scholar 

  95. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143–9.

    PubMed  CAS  Google Scholar 

  96. Nikolsky E, Aymong ED, Dangas G, Mehran R. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med. 2003;4 Suppl 1:S7–14.

    PubMed  Google Scholar 

  97. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.

    PubMed  Google Scholar 

  98. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95:13–9.

    PubMed  Google Scholar 

  99. McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98:27K–36.

    PubMed  Google Scholar 

  100. Tan N, Liu Y, Zhou YL, et al. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2012;79(1):70–5.

    PubMed  Google Scholar 

  101. Kumar N, Dahri L, Brown W, et al. Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol. 2009;4: 1907–13.

    PubMed Central  PubMed  Google Scholar 

  102. Lorenz EC, Stegall MD, Cosio FG, Gloor JM, Larson TS, Taler SJ. The effect of coronary angiography on renal function in preemptive renal transplant candidates. Clin Transplant. 2011;25: 594–9.

    PubMed  Google Scholar 

  103. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58:e123–210.

    PubMed  Google Scholar 

  104. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44–122.

    PubMed  Google Scholar 

  105. Patel MR, Bailey SR, Bonow RO, et al. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;59:1995–2027.

    PubMed  Google Scholar 

  106. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006;70:2021–30.

    PubMed Central  PubMed  CAS  Google Scholar 

  107. Poldermans D, Schouten O, Vidakovic R, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007;49:1763–9.

    PubMed  Google Scholar 

  108. Szczech LA, Reddan DN, Owen WF, et al. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int. 2001;60:292–9.

    PubMed  CAS  Google Scholar 

  109. Reddan DN, Szczech LA, Tuttle RH, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003;14:2373–80.

    PubMed  Google Scholar 

  110. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation. 2004;109:2866–71.

    PubMed  Google Scholar 

  111. Debella YT, Giduma HD, Light RP, Agarwal R. Chronic kidney disease as a coronary disease equivalent—a comparison with diabetes over a decade. Clin J Am Soc Nephrol. 2011;6:1385–92.

    PubMed Central  PubMed  Google Scholar 

  112. Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013;127:1861–9.

    Google Scholar 

  113. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA. 2005;293:1501–8.

    PubMed  CAS  Google Scholar 

  114. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery). Circulation. 2004;110:e340–437.

    PubMed  Google Scholar 

  115. Liu JY, Birkmeyer NJ, Sanders JH, et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 2000;102:2973–7.

    PubMed  CAS  Google Scholar 

  116. Tsai TT, Messenger JC, Brennan JM, et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J Am Coll Cardiol. 2011;58:1859–69.

    PubMed  Google Scholar 

  117. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology. 2008;109:596–604.

    PubMed  Google Scholar 

  118. Nuttall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology. 2008;109:588–95.

    PubMed  Google Scholar 

  119. van Kuijk JP, Flu WJ, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol. 2009;104:1229–34.

    PubMed  Google Scholar 

  120. Anwaruddin S, Askari AT, Saudye H, et al. Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv. 2009;2:542–9.

    PubMed  Google Scholar 

  121. Grines CL, Bonow RO, Casey Jr DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007;49:734–9.

    PubMed  CAS  Google Scholar 

  122. Kendrick E. Cardiovascular disease and the renal transplant recipient. Am J Kidney Dis. 2001;38:S36–43.

    PubMed  CAS  Google Scholar 

  123. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section I: evaluation, selection and preparation of the potential transplant recipient. I.5. Risk factors/relative contra-indications. Nephrol Dial Transplant. 2000;15 Suppl 7:3–38.

    Google Scholar 

  124. Lentine KL, Hurst FP, Jindal RM, et al. Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis. 2010;55: 152–67.

    PubMed Central  PubMed  Google Scholar 

  125. Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123:e426–579.

    PubMed  Google Scholar 

  126. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977–2016.

    PubMed  Google Scholar 

  127. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523–661.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Outcomes Research, Abdominal Transplant Program, Saint Louis University School of Medicine, Salus Center, 3545 Lafayette Avenue, St. Louis, MO, 63104, USA

    Krista L. Lentine M.D., Ph.D.

  2. Abdominal Transplant Program, Saint Louis University School of Medicine, St. Louis, MO, USA

    Krista L. Lentine M.D., Ph.D.

  3. Cardiology Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA

    Todd C. Villines M.D.

  4. Nephrology Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA

    Kevin C. Abbott M.D., M.P.H.

  5. Cardiology Section, Department of Medicine, Dartmouth Hitchcock Medical Center, Hanover, NH, USA

    Salvatore P. Costa M.D.

Authors
  1. Krista L. Lentine M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Todd C. Villines M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin C. Abbott M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Salvatore P. Costa M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Krista L. Lentine M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Nephrology, University of Maryland, Baltimore, Maryland, USA

    Matthew R. Weir

  2. Department of Medicine, Section of Nephrology, University of Illinois, Berwyn, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lentine, K.L., Villines, T.C., Abbott, K.C., Costa, S.P. (2014). Preoperative Cardiovascular Evaluation and Management. In: Weir, M., Lerma, E. (eds) Kidney Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0342-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0342-9_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0341-2

  • Online ISBN: 978-1-4939-0342-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation